What is the recommended management and secondary prophylaxis for rheumatic heart disease?

Management and Secondary Prophylaxis for Rheumatic Heart Disease

All patients with rheumatic heart disease must receive long-term antibiotic prophylaxis to prevent recurrent rheumatic fever, with intramuscular benzathine penicillin G every 4 weeks as the preferred regimen. 1

Secondary Prophylaxis Regimens

The following antibiotic options are available for secondary prevention, listed in order of preference:

First-Line Treatment

• Benzathine penicillin G (Penicillin G benzathine): 1.2 million units intramuscularly every 4 weeks 1
  • In high-risk situations (severe valvular disease, high streptococcal exposure, history of recurrence despite adherence), administer every 3 weeks 1
  • This regimen is approximately 10 times more effective than oral antibiotics at preventing rheumatic fever recurrence 2

Alternative Oral Regimens (for patients who refuse injections or have contraindications)

• Penicillin V potassium: 250 mg orally twice daily 1
• Sulfadiazine: 1 g orally once daily 1
• Macrolide or azalide antibiotic: Varies (for patients allergic to both penicillin and sulfadiazine) 1
  • Critical caveat: Do not use macrolides in patients taking cytochrome P450 3A inhibitors (azole antifungals, HIV protease inhibitors, some SSRIs) 1

Duration of Prophylaxis

The duration depends on the severity of initial cardiac involvement and is risk-stratified as follows:

Rheumatic Fever WITH Carditis AND Residual Heart Disease (Persistent Valvular Disease)

• Duration: 10 years after last attack OR until age 40 years (whichever is longer) 1
• Consider lifelong prophylaxis if high risk of group A streptococcus exposure 1
• Prophylaxis is required even after valve replacement 1

Rheumatic Fever WITH Carditis BUT NO Residual Heart Disease

• Duration: 10 years after last attack OR until age 21 years (whichever is longer) 1

Rheumatic Fever WITHOUT Carditis

• Duration: 5 years after last attack OR until age 21 years (whichever is longer) 1

Critical Safety Considerations for Benzathine Penicillin G

Recent evidence indicates patients with severe valvular disease may be at elevated risk of cardiovascular compromise following benzathine penicillin G injections. 3

Elevated-Risk Patients (Consider Oral Prophylaxis Instead)

Patients with the following conditions should have oral prophylaxis strongly considered over intramuscular benzathine penicillin G:

• Severe mitral stenosis 3
• Severe aortic stenosis 3
• Severe aortic insufficiency 3
• Decreased left ventricular systolic dysfunction 3
• Symptomatic heart failure 3

Risk Mitigation Strategies for All Patients Receiving Benzathine Penicillin G

• Implement multifaceted vasovagal risk reduction strategies 3
• Ensure resources available to manage anaphylaxis and severe adverse reactions 4
• Consider co-administration of lidocaine/analgesics to reduce injection pain 4
• Monitor for severe adverse reactions and establish pharmacovigilance systems 4

Additional Management Principles

General Medical Therapy

• Maintain standard guideline-directed medical therapy for cardiac risk factors (hypertension, diabetes, hyperlipidemia) 1
• Continue heart failure medications if indicated (ACE inhibitors, ARBs, beta blockers, aldosterone antagonists, sacubitril/valsartan) 1
• Avoid abrupt blood pressure lowering in patients with stenotic valve lesions 1
• Encourage regular aerobic exercise for cardiovascular fitness in asymptomatic patients 1

Infective Endocarditis Prophylaxis

• Antibiotic prophylaxis is reasonable before dental procedures involving gingival manipulation, periapical manipulation, or oral mucosa perforation in patients with prosthetic valves, prosthetic valve repair material, or previous infective endocarditis 1
• Optimal oral health maintenance is the most important preventive measure 1

Vaccinations

• Administer influenza and pneumococcal vaccinations per standard recommendations 1

Key Clinical Pitfalls

Recurrent rheumatic fever worsens rheumatic heart disease progressively, and group A streptococcus infection does not need to be symptomatic to trigger recurrence. 1 This underscores why continuous prophylaxis is superior to treating acute pharyngitis episodes. 1

Prophylaxis adherence is critical: Intramuscular benzathine penicillin G demonstrates superior efficacy (RR 0.07 for recurrence vs. oral antibiotics), but barriers include injection pain, fear of adverse reactions among healthcare providers, and medication shortages in endemic regions. 5, 4, 2